bromfenac sodium salt sesquihydrate structure
|
Common Name | bromfenac sodium salt sesquihydrate | ||
|---|---|---|---|---|
| CAS Number | 120638-55-3 | Molecular Weight | 383.17 | |
| Density | 1.6±0.1 g/cm3 | Boiling Point | 562.2±50.0 °C at 760 mmHg | |
| Molecular Formula | C15H12BrNO3.3/2H2O.Na | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 293.8±30.1 °C | |
Use of bromfenac sodium salt sesquihydrateBromfenac (sodium hydrate) is a nonsteroidal anti-inflammatory drug (NSAID), which has anti-inflammatory activity(1) Bromfenac (sodium hydrate) (1 mg/kg, i.v.) is metabolited into an unusual conjugate, bromfenac N-glucoside, in rats bile(2) Bromfenac (sodium hydrate) permeation was found to be 1.62-fold higher through ChS-CS-NPs |
| Name | bromfenac sodium salt sesquihydrate |
|---|---|
| Synonym | More Synonyms |
| Description | Bromfenac (sodium hydrate) is a nonsteroidal anti-inflammatory drug (NSAID), which has anti-inflammatory activity(1) Bromfenac (sodium hydrate) (1 mg/kg, i.v.) is metabolited into an unusual conjugate, bromfenac N-glucoside, in rats bile(2) Bromfenac (sodium hydrate) permeation was found to be 1.62-fold higher through ChS-CS-NPs |
|---|---|
| Related Catalog | |
| References |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Boiling Point | 562.2±50.0 °C at 760 mmHg |
| Molecular Formula | C15H12BrNO3.3/2H2O.Na |
| Molecular Weight | 383.17 |
| Flash Point | 293.8±30.1 °C |
| PSA | 80.39000 |
| LogP | 2.72 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.663 |
| Storage condition | 2-8℃ |
| Sodium (2-amino-3-(4-bromobenzoyl)phenyl)acetate |
| bromfenacum [INN_la] |
| Bromfenac monosodium salt sesquihydrate |
| Unii-8ecv571Y37 |
| [2-Amino-3-(4-bromobenzoyl)phenyl]acetic acid |
| BroMfenac sodiuM 1.5H2O |
| Bromfenac Sodium Sesquihydrate |
| Bromfenac ophthalmic |
| Bromfenac ophthalmic solution |
| Benzeneacetic acid, 2-amino-3-(4-bromobenzoyl)- |
| bromfenac |
| Bromfenac sodium |
| Duract |
| Bromfenac (sodium hydrate) |